Literature DB >> 15112301

A comparison of Ktrans measurements obtained with conventional and first pass pharmacokinetic models in human gliomas.

Hamied A Haroon1, David L Buckley, Tufail A Patankar, Graham R Dow, Scott A Rutherford, Danielle Balériaux, Alan Jackson.   

Abstract

PURPOSE: To compare in a group of patients with cerebral gliomas the estimates of Ktrans between a conventionally established pharmacokinetic model and a recently developed first pass method.
MATERIALS AND METHODS: Glioma patients (23) were studied using T1-weighted dynamic contrast-enhanced magnetic resonance imaging (MRI), and two alternative pharmacokinetic models were used for analysis to derive the volume transfer constant Ktrans. These were a modified version of the established model (yielding KTK) and a recently published method based on first pass leakage profile (FP) of contrast bolus (yielding Kfp).
RESULTS: We found a strong correlation between intra-tumoral median KTK and Kfp (rho = 0.650, P < 0.01), but the values from the conventional model were consistently and significantly higher (mean of inter-tumoral Kfp and KTK medians were 0.018 minute(-1) and 0.284 minute(-1), respectively, P < 0.001). The spatial distribution of KTK and Kfp showed poor correlation in the presence of large vascular structures and good correlation elsewhere.
CONCLUSION: KTK and Kfp produce similar biologic information within voxels not dominated by vascular tissue. The FP method avoids erroneous overestimation of Ktrans in areas of significant intravascular contrast. Findings are in keeping with the predictions of previous mathematical simulations. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112301     DOI: 10.1002/jmri.20045

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  A continuous-infusion dynamic MRI model at 3.0 Tesla for the serial quantitative evaluation of microvascular proliferation in an animal model of glioblastoma multiforme.

Authors:  Hunter R Underhill
Journal:  Magn Reson Med       Date:  2017-01-12       Impact factor: 4.668

2.  Quantitative dynamic contrast-enhanced MR imaging shows widespread blood-brain barrier disruption in mild traumatic brain injury patients with post-concussion syndrome.

Authors:  Roh-Eul Yoo; Seung Hong Choi; Byung-Mo Oh; Sang Do Shin; Eun Jung Lee; Dong Jae Shin; Sang Won Jo; Koung Mi Kang; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2018-07-31       Impact factor: 5.315

3.  Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.

Authors:  Vera C Keil; Bogdan Pintea; Gerrit H Gielen; Susanne Greschus; Rolf Fimmers; Jürgen Gieseke; Matthias Simon; Hans H Schild; Dariusch R Hadizadeh
Journal:  J Neurooncol       Date:  2017-04-19       Impact factor: 4.130

Review 4.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

5.  Dynamic contrast-enhanced MR imaging in predicting progression of enhancing lesions persisting after standard treatment in glioblastoma patients: a prospective study.

Authors:  Roh-Eul Yoo; Seung Hong Choi; Tae Min Kim; Chul-Kee Park; Sung-Hye Park; Jae-Kyung Won; Il Han Kim; Soon Tae Lee; Hye Jeong Choi; Sung-Hye You; Koung Mi Kang; Tae Jin Yun; Ji-Hoon Kim; Chul-Ho Sohn
Journal:  Eur Radiol       Date:  2016-12-14       Impact factor: 5.315

6.  Glioma: Application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading.

Authors:  S C Jung; J A Yeom; J-H Kim; I Ryoo; S C Kim; H Shin; A L Lee; T J Yun; C-K Park; C-H Sohn; S-H Park; S H Choi
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-02       Impact factor: 3.825

7.  Is volume transfer coefficient (K(trans)) related to histologic grade in human gliomas?

Authors:  Tufail F Patankar; Hamied A Haroon; Samantha J Mills; Danielle Balériaux; David L Buckley; Geoff J M Parker; Alan Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

8.  Dual contrast perfusion MRI in a single imaging session for assessment of pediatric brain tumors.

Authors:  Eric M Thompson; Daniel J Guillaume; Edit Dósa; Xin Li; Kellie J Nazemi; Seymur Gahramanov; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  J Neurooncol       Date:  2012-04-19       Impact factor: 4.130

9.  Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma?

Authors:  S J Mills; T A Patankar; H A Haroon; D Balériaux; R Swindell; A Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

10.  Inhibition of SUR1 decreases the vascular permeability of cerebral metastases.

Authors:  Eric M Thompson; Gregory L Pishko; Leslie L Muldoon; Edward A Neuwelt
Journal:  Neoplasia       Date:  2013-05       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.